Versant Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $717K | Sell |
1,980
-672
| -25% | -$230K | 0.06% | 190 |
|
|
2026
Q1 | $933K | Buy |
2,652
+485
| +22% | +$173K | 0.09% | 137 |
|
|
2025
Q4 | $709K | Buy |
2,167
+119
| +6% | +$37.7K | 0.09% | 145 |
|
|
2025
Q3 | $578K | Buy |
2,048
+512
| +33% | +$148K | 0.08% | 168 |
|
|
2025
Q2 | $429K | Sell |
1,536
-281
| -15% | -$79.6K | 0.07% | 218 |
|
|
2025
Q1 | $566K | Buy |
1,817
+594
| +49% | +$175K | 0.1% | 130 |
|
|
2024
Q4 | $319K | Buy |
1,223
+156
| +15% | +$46.3K | 0.07% | 132 |
|
|
2024
Q3 | $344K | Buy |
1,067
+116
| +12% | +$37.9K | 0.08% | 107 |
|
|
2024
Q2 | $297K | Sell |
951
-13
| -1% | -$3.82K | 0.08% | 103 |
|
|
2024
Q1 | $274K | Buy |
964
+32
| +3% | +$9.36K | 0.08% | 106 |
|
|
2023
Q4 | $268K | Sell |
932
-12
| -1% | -$3.27K | 0.08% | 107 |
|
|
2023
Q3 | $254K | Buy |
944
+3
| +0.3% | +$749 | 0.08% | 108 |
|
|
2023
Q2 | $209K | Sell |
941
-176
| -16% | -$40.8K | 0.07% | 121 |
|
|
2023
Q1 | $270K | Buy |
1,117
+23
| +2% | +$5.65K | 0.09% | 100 |
|
|
2022
Q4 | $287K | Buy |
1,094
+2
| +0.2% | +$536 | 0.1% | 81 |
|
|
2022
Q3 | $246K | Buy |
1,092
+1
| +0.1% | +$242 | 0.1% | 90 |
|
|
2022
Q2 | $265K | Hold |
1,091
| – | – | 0.1% | 91 |
|
|
2022
Q1 | $264K | Buy |
1,091
+646
| +145% | +$148K | 0.08% | 94 |
|
|
2021
Q4 | $100K | Sell |
445
-6
| -1% | -$1.27K | 0.03% | 156 |
|
|
2021
Q3 | $96K | Sell |
451
-11
| -2% | -$2.53K | 0.03% | 154 |
|
|
2021
Q2 | $113K | Sell |
462
-126
| -21% | -$31K | 0.04% | 133 |
|
|
2021
Q1 | $146K | Buy |
588
+3
| +0.5% | +$716 | 0.05% | 125 |
|
|
2020
Q4 | $134K | Hold |
585
| – | – | 0.05% | 125 |
|
|
2020
Q3 | $148K | Hold |
585
| – | – | 0.07% | 111 |
|
|
2020
Q2 | $138K | Buy |
585
+3
| +0.5% | +$684 | 0.06% | 113 |
|
|
2020
Q1 | $117K | Sell |
582
-53
| -8% | -$11.6K | 0.06% | 115 |
|
|
2019
Q4 | $153K | Sell |
635
-5
| -0.8% | -$1.1K | 0.08% | 96 |
|
|
2019
Q3 | $123K | Buy |
640
+22
| +4% | +$4.22K | 0.06% | 111 |
|
|
2019
Q2 | $113K | Sell |
618
-214
| -26% | -$38.3K | 0.05% | 116 |
|
|
2019
Q1 | $158K | Buy |
832
+17
| +2% | +$3.25K | 0.07% | 109 |
|
|
2018
Q4 | $158K | Hold |
815
| – | – | 0.07% | 103 |
|
|
2018
Q3 | $168K | Sell |
815
-2
| -0.2% | -$394 | 0.07% | 104 |
|
|
2018
Q2 | $150K | Hold |
817
| – | – | 0.06% | 112 |
|
|
2018
Q1 | $139K | Sell |
817
-3
| -0.4% | -$551 | 0.06% | 120 |
|
|
2017
Q4 | $142K | Buy |
820
+38
| +5% | +$6.72K | 0.06% | 118 |
|
|
2017
Q3 | $145K | Sell |
782
-137
| -15% | -$24.3K | 0.08% | 95 |
|
|
2017
Q2 | $158K | Hold |
919
| – | – | 0.09% | 87 |
|
|
2017
Q1 | $150K | Hold |
919
| – | – | 0.08% | 95 |
|
|
2016
Q4 | $134K | Sell |
919
-45
| -5% | -$6.77K | 0.08% | 100 |
|
|
2016
Q3 | $160K | Sell |
964
-25
| -3% | -$4.23K | 0.09% | 90 |
|
|
2016
Q2 | $150K | Sell |
989
-23
| -2% | -$3.58K | 0.09% | 90 |
|
|
2016
Q1 | $151K | Sell |
1,012
-28
| -3% | -$4.16K | 0.09% | 89 |
|
|
2015
Q4 | $168K | Buy |
+1,040
| New | +$163K | 0.11% | 81 |
|
Other funds holding AMGN
SP
SMDAM
CRM
FWCM
Versant Capital Management's AMGN Position: Q2 2026 in Review
Versant Capital Management reduced its Amgen (AMGN) stake by 25% in Q2 2026, selling an estimated $230K and leaving 1,980 shares worth $717K. The position accounts for 0.06% of the portfolio, ranked #190.
Versant Capital Management first reported a position in AMGN in Q4 2015 and has held it in 43 quarters since. The position peaked at $933K in Q1 2026. 906 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Versant Capital Management held 1,980 shares of Amgen worth $717K as of Q2 2026.
- Versant Capital Management sold 672 Amgen shares in Q2 2026, an estimated $230K.
- Amgen made up 0.06% of Versant Capital Management's portfolio in Q2 2026, its #190 holding.
- Versant Capital Management first reported a position in Amgen in Q4 2015 and has held it in 43 quarters since.
- Versant Capital Management's Amgen position peaked at $933K in Q1 2026.
- 906 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.